{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:39:57Z","timestamp":1791895197167,"version":"4.3.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1136\/ard.2007.081513","type":"journal-article","created":{"date-parts":[[2007,12,14]],"date-time":"2007-12-14T01:45:10Z","timestamp":1197596710000},"page":"710-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease"],"prefix":"10.1016","volume":"67","author":[{"given":"E J","family":"Cepeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F M","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Reveille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.081513_bib1","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/00002030-199112000-00001","article-title":"Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?","volume":"5","author":"Matsuyama","year":"1991","journal-title":"AIDS"},{"key":"10.1136\/ard.2007.081513_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/smim.1993.1020","article-title":"Cytokine modulation of HIV expression","volume":"5","author":"Poli","year":"1993","journal-title":"Semin Immunol"},{"key":"10.1136\/ard.2007.081513_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/169.2.420","article-title":"Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection\u2014correlations to clinical, immunologic, and virologic parameters","volume":"169","author":"Aukrust","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1136\/ard.2007.081513_bib4","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1002\/art.11301","article-title":"Infections and anti-tumor necrosis factor alpha therapy","volume":"48","author":"Ellerin","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081513_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4065\/75.10.1093","article-title":"Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis","volume":"75","author":"Aboulafia","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1136\/ard.2007.081513_bib6","first-page":"1353","article-title":"Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection","volume":"34","author":"Linardaki","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081513_bib7","first-page":"407","article-title":"Infliximab in the treatment of an HIV positive patient with Reiter's syndrome","volume":"30","author":"Gaylis","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.081513_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.0007-0963.2004.05885.x","article-title":"Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab","volume":"150","author":"Bartke","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard.2007.081513_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jbspin.2006.05.012","article-title":"Use of infliximab to treat psoriatic arthritis in HIV-positive patients","volume":"74","author":"Sellam","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"Suppl 2","key":"10.1136\/ard.2007.081513_bib10","doi-asserted-by":"crossref","first-page":"ii18","DOI":"10.1136\/ard.2004.028209","article-title":"Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection","volume":"63","author":"Calabrese","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081513_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bjo.87.7.925","article-title":"Does etanercept induce uveitis?","volume":"87","author":"Reddy","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1136\/ard.2007.081513_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.62.1.88","article-title":"Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors","volume":"62","author":"Kaipiainen-Seppanen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.081513_bib13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","article-title":"Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.081513_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/infdis\/174.1.63","article-title":"Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1","volume":"174","author":"Walker","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1136\/ard.2007.081513_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1089\/088922202760019365","article-title":"Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2","volume":"18","author":"Sha","year":"2002","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421815X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672421815X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.081513","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T01:38:24Z","timestamp":1737250704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672421815X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S000349672421815X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.081513","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.081513","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 2008 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}